Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34,245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study.
Liu F, Yang W, Yang W, Xu R, Chen L, He Y, Liu Z, Zhou F, Hou B, Zhang L, Zhang L, Zhang F, Cai F, Xu H, Lin M, Liu M, Pan Y, Liu Y, Hu Z, Chen H, He Z, Ke Y. Liu F, et al. Among authors: zhang l, zhang f. Ann Surg. 2023 Apr 1;277(4):e777-e784. doi: 10.1097/SLA.0000000000005296. Epub 2021 Nov 11. Ann Surg. 2023. PMID: 35129490
Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma.
Liang L, Liu F, Yang W, Yang W, Chen L, He Y, Liu Z, Zhang L, Zhang F, Cai F, Xu H, Lin M, Liu M, Pan Y, Liu Y, Hu Z, Chen H, He Z, Ke Y. Liang L, et al. Among authors: zhang l, zhang f. Ann Surg Oncol. 2022 Sep;29(9):5626-5633. doi: 10.1245/s10434-022-11415-5. Epub 2022 Feb 18. Ann Surg Oncol. 2022. PMID: 35181817
[No title available]
[No authors listed] [No authors listed] PMID: 35366703
Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-World Data.
Yang W, Liu F, Xu R, Yang W, He Y, Liu Z, Zhou F, Heng F, Hou B, Zhang L, Chen L, Zhang F, Cai F, Xu H, Lin M, Liu M, Pan Y, Liu Y, Hu Z, Chen H, He Z, Ke Y. Yang W, et al. Among authors: zhang l, zhang f. Ann Surg. 2023 Jan 1;277(1):e61-e69. doi: 10.1097/SLA.0000000000004958. Epub 2021 Jun 2. Ann Surg. 2023. PMID: 34091512
Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China.
Tian H, Yang W, Hu Y, Liu Z, Chen L, Lei L, Zhang F, Cai F, Xu H, Liu M, Guo C, Chen Y, Xiao P, Chen J, Ji P, Fang Z, Liu F, Liu Y, Pan Y, Dos-Santos-Silva I, He Z, Ke Y. Tian H, et al. Among authors: zhang f. EClinicalMedicine. 2020 Mar 20;20:100312. doi: 10.1016/j.eclinm.2020.100312. eCollection 2020 Mar. EClinicalMedicine. 2020. PMID: 32215367 Free PMC article.
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial.
Peng H, Chen L, Zhang Y, Li WF, Mao YP, Zhang F, Guo R, Liu LZ, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: zhang f, zhang y. Oncologist. 2016 Nov;21(11):1369-1376. doi: 10.1634/theoncologist.2016-0105. Epub 2016 Aug 5. Oncologist. 2016. PMID: 27496040 Free PMC article.
34,245 results
You have reached the last available page of results. Please see the User Guide for more information.